Dr. McNeill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Montefiore Medical Center
111 E 210th St
Bronx, NY 10467Phone+1 718-920-4057
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 2006 - 2009
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2005 - 2006
- University of Maryland School of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2013 - 2026
- MD State Medical License 2008 - 2015
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas Start of enrollment: 2010 May 01
- Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 1 citationsProspective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, Merit E Cudkowicz, Robin A Conwit
Neuro-Oncology Advances. 2021-12-24 - 236 citationsEpidemiology of Brain Tumors.Katharine A. McNeill
Neurologic Clinics. 2016-11-01 - 104 citationsMolecular characterizations of glioblastoma, targeted therapy, and clinical results to date.Jayson Bastien, Katharine A. McNeill, Howard A. Fine
Cancer. 2015-02-15
Journal Articles
- Challenges in clinical trial design for recurrent glioblastomaMcNeill, KA, Fine, HA, Clinical Investigation, 9/2013
- Chemoirradiation for glioblastoma multiforme: the national cancer institute experienceHo, J, Ondos, J, Ning, H, Smith, S, Kreisl, T, Iwamoto, F, Kim, L, McNeill, K, Krauze, A, Shankavaram, U, Fine, HA, Camphausen, K, PLoS One, 8/2013
- A phase I/II trial of vandetanib for patients with recurrent malignant gliomaKreisl, TN, Mcneill KA, Sul J, Iwamoto F, Shih J, Fine HA, Neuro-Oncology, 12/2012
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: